Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics, Inc. (LENZ) Operating Leases (2022 - 2023)

LENZ Therapeutics (LENZ) has disclosed Operating Leases for 2 consecutive years, with $49.7 million as the latest value for Q3 2023.

  • On a quarterly basis, Operating Leases rose 1886.88% to $49.7 million in Q3 2023 year-over-year; TTM through Sep 2023 was $49.7 million, a 1886.88% increase, with the full-year FY2022 number at $1.7 million, changed N/A from a year prior.
  • Operating Leases was $49.7 million for Q3 2023 at LENZ Therapeutics, down from $50.6 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $50.6 million in Q2 2023 to a low of $1.4 million in Q1 2023.